ArticleFrontiers in pharmacology2026

Life-threatening anaphylactic shock induced by cadonilimab (AK104), a PD-1/CTLA-4 bispecific antibody: a case report.

Zhiming Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.